Clinical Trial Update: Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a new anti-cancer vaccine in patients with Non-small cell lung cancer after tumor removal by surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Unspecified cancer vaccine (trial product)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Non-Small Cell | Phase 1 | Status: TERMINATED